Results 11 to 20 of about 15,233 (195)

Review paper Post-Lyme disease syndrome [PDF]

Rheumatology, 2015
About 10% of patients with Lyme disease continue to experience musculoskeletal pain and cognitive dysfunction after recommended antibiotic treatment.
Joanna Ścieszka, Józefa Dąbek, Paweł Cieślik   +2 more
doaj   +5 more sources

Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome

Microorganisms, 2021
The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of ...
Kristyna Sloupenska, Jana Dolezilkova, Barbora Koubkova, Beata Hutyrova, Mojmir Racansky, Pavel Horak, Maryna Golovchenko, Milan Raska, Natalie Rudenko, Michal Krupka   +9 more
doaj   +3 more sources

The Relationship Between Hemodynamic Responses During Head-Up Tilt Testing and Parameters of Infection in Post-COVID Syndrome, Chronic Fatigue Syndrome, and Late-Stage Lyme Disease [PDF]

Viruses
Autonomic nervous system (ANS) dysfunction has emerged as a central feature of post-infectious syndromes, including post-COVID syndrome (PCS), chronic fatigue syndrome (CFS), and late-stage Lyme disease.
Branislav Milovanovic, Nikola Markovic, Masa Petrovic, Smiljana Stojanovic, Vasko Zugic, Milijana Ostojic, Milovan Bojic   +6 more
doaj   +2 more sources

Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome

Life, 2023
Most patients suffering from Lyme disease are effectively treated with antibiotics. In some patients, however, problems persist for a long time despite appropriate therapy.
Kristyna Sloupenska, Barbora Koubkova, Pavel Horak, Beata Hutyrova, Mojmir Racansky, Jan Mares, Martina Miklusova, Jan Schovanek, Jana Zapletalova, Milan Raska, Michal Krupka   +10 more
doaj   +3 more sources

Update of the Swiss guidelines on post-treatment Lyme disease syndrome [PDF]

Swiss Medical Weekly, 2016
Lyme borreliosis is caused by Borrelia burgdorferi sensu lato infection, which responds well to antibiotic therapy in the overwhelming majority of cases.
Johannes Nemeth, Enos Bernasconi, Ulrich Heininger, Mohamed Abbas, David Nadal, Carol Strahm, Stefan Erb, Stefan Zimmerli, Hansjakob Furrer, Julie Delaloye, Thierry Kuntzer, Ekkehard Altpeter, Mathias Sturzenegger, Rainer Weber, for the Swiss Society for Infectious Diseases and the Swiss Society for Neurology   +14 more
doaj   +5 more sources

Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review

Antibiotics, 2020
Three patients with multi-year histories of relapsing and remitting Lyme disease and associated co-infections despite extended antibiotic therapy were each given double-dose dapsone combination therapy (DDD CT) for a total of 7–8 weeks. At the completion
Richard I. Horowitz, Phyllis R. Freeman
doaj   +3 more sources

Evaluation of immunoreactive epitopes in the sera and cerebrospinal fluid of patients with post-treatment Lyme disease syndrome [PDF]

Scientific Reports
While most patients fully recover after treatment for Lyme disease with recommended antibiotic regimens, some report non-specific symptoms after treatment. When these symptoms are unexplained by other conditions and persist for ≥ 6 months, this condition
Adriana R. Marques, Santiago Sanchez-Vicente, Akash Nagapurkar, Aleah Eschman, Siu Ping Ng, W. Ian Lipkin, Rafal Tokarz   +6 more
doaj   +2 more sources

Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?

Frontiers in Neurology
Dysautonomia, or dysfunction of the autonomic nervous system (ANS), may occur following an infectious insult and can result in a variety of debilitating, widespread, and often poorly recognized symptoms.
Brittany L. Adler, Tae Chung, Peter C. Rowe, John Aucott   +3 more
doaj   +3 more sources

Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review

Antibiotics, 2022
Lyme disease and associated co-infections are increasing worldwide and approximately 20% of individuals develop chronic Lyme disease (CLD)/Post-Treatment Lyme Disease Syndrome (PTLDS) despite early antibiotics.
Richard I. Horowitz, Phyllis R. Freeman
doaj   +3 more sources

Autonomic Symptoms in Post-Treatment Lyme Disease: Insights From the COMPASS-31 and the 10-Minute Active Stand Test [PDF]

Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective: To determine the prevalence of autonomic symptoms in post-treatment Lyme disease (PTLD) and identify clinical factors that associate with abnormal hemodynamics on the 10-minute active stand test.
Brittany L. Adler, MD, Alison W. Rebman, MPH, Tae Chung, MD, John B. Miller, MD, Marzieh Keshtkarjahromi, MD, MPH, Ting Yang, PhD, Chatuthanai Savigamin, MD, MSc, MPH, Alba Azola, MD, Peter C. Rowe, MD, John N. Aucott, MD   +9 more
doaj   +2 more sources